The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence mortality and cost

被引:42
作者
Goldman, L
Phillips, KA
Coxson, P
Goldman, PA
Williams, L
Hunink, M
Weinstein, MC
机构
[1] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
[4] Harvard Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Erasmus Univ, Med Ctr, Program Assessment Radiol Technol, Dept Radiol, Rotterdam, Netherlands
[7] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands
关键词
D O I
10.1016/S0735-1097(01)01512-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to estimate the impact and cost-effectiveness of risk factor reductions between 1981 and 1990. BACKGROUND Coronary heart disease (CHD) mortality rates have declined dramatically, partly as a result of reductions in CHD risk factors. METHODS We used the CHD Policy Model, a validated computer-simulation model, to estimate the effects of actual investments made to change coronary risk factors between 1981 and 1990, as well as the impact of these changes on the incidence, prevalence, mortality and costs of CHD during this period and projected to 2015. RESULTS Observed changes in risk factors between 1981 and 1990 resulted in a reduction of CHD deaths by similar to 430,000 and overall deaths by similar to 740,000, with an estimated cost-effectiveness of about $44,000 per year of life saved during this period, based on the estimated actual costs of the interventions used. However, because much of the benefit of risk factor reductions is delayed, the estimated reductions for the 35-year period of 1981 to 2015 were 3.6 million CHD deaths and 1.2 million non-CHD deaths, at a cost of only about $5,400 per year of life saved. CONCLUSIONS Aggregate efforts to reduce risk factors between 1981 and 1990 have led to substantial reductions in CHD and should be well worth the cost, largely because of population-wide changes in life-style and habits. Some interventions are much better investments than others, and attention to such issues could lead to better use of resources and better outcomes in the future. (C) 2001 by the American College of Cardiology.
引用
收藏
页码:1012 / 1017
页数:6
相关论文
共 40 条
[1]  
*AM HEART ASS, 1999, EC COSTS CARD DIS
[2]   Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation [J].
Cromwell, J ;
Bartosch, WJ ;
Fiore, MC ;
Hasselblad, V ;
Baker, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (21) :1759-1766
[3]  
*CTR DIS CONTR, 2000, MMWR-MORBID MORTAL W, V49, P665
[4]   Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs [J].
Daviglus, ML ;
Liu, KA ;
Greenland, P ;
Dyer, AR ;
Garside, DB ;
Manheim, L ;
Lowe, LP ;
Rodin, M ;
Lubitz, J ;
Stamler, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (16) :1122-1129
[5]  
Elder JP, 1996, PUBLIC HEALTH REP, V111, P353
[6]   CORONARY HEART-DISEASE IN RESIDENTS OF ROCHESTER, MINNESOTA .5. PROGNOSIS OF PATIENTS WITH CORONARY HEART-DISEASE BASED ON INITIAL MANIFESTATION [J].
ELVEBACK, LR ;
CONNOLLY, DC .
MAYO CLINIC PROCEEDINGS, 1985, 60 (05) :305-311
[7]  
FEINLEIB M, 1989, CIRCULATION, V79, P13
[8]   METHODS USED TO QUIT SMOKING IN THE UNITED-STATES - DO CESSATION PROGRAMS HELP [J].
FIORE, MC ;
NOVOTNY, TE ;
PIERCE, JP ;
GIOVINO, GA ;
HATZIANDREU, EJ ;
NEWCOMB, PA ;
SURAWICZ, TS ;
DAVIS, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (20) :2760-2765
[9]   COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE [J].
GOLDMAN, L ;
WEINSTEIN, MC ;
GOLDMAN, PA ;
WILLIAMS, LW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (09) :1145-1151
[10]   The relative influence of secondary versus primary prevention using the national cholesterol education program adult treatment panel II guidelines [J].
Goldman, L ;
Coxson, P ;
Hunink, MGM ;
Goldman, PA ;
Tosteson, ANA ;
Mittleman, M ;
Williams, L ;
Weinstein, MC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) :768-776